Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 140

1.

Antitumor effects of heparin-polyethyleneimine nanogels delivering claudin-3-targeted short hairpin RNA combined with low-dose cisplatin on ovarian cancer.

Liu L, Gou M, Yi T, Bai Y, Wei Y, Zhao X.

Oncol Rep. 2014 Apr;31(4):1623-8. doi: 10.3892/or.2014.2995. Epub 2014 Jan 24.

PMID:
24482188
2.

The enhanced antitumor effects of biodegradable cationic heparin-polyethyleneimine nanogels delivering HSulf-1 gene combined with cisplatin on ovarian cancer.

Liu P, Gou M, Yi T, Qi X, Xie C, Zhou S, Deng H, Wei Y, Zhao X.

Int J Oncol. 2012 Oct;41(4):1504-12. doi: 10.3892/ijo.2012.1558. Epub 2012 Jul 18.

PMID:
22825572
3.

Efficient inhibition of ovarian cancer by recombinant CXC chemokine ligand 10 delivered by novel biodegradable cationic heparin-polyethyleneimine nanogels.

Yang F, Gou M, Deng H, Yi T, Zhong Q, Wei Y, Zhao X.

Oncol Rep. 2012 Aug;28(2):668-76. doi: 10.3892/or.2012.1853. Epub 2012 Jun 6.

PMID:
22684947
4.

Efficient Inhibition of Ovarian Cancer by Gelonin Toxin Gene Delivered by Biodegradable Cationic Heparin-polyethyleneimine Nanogels.

Bai Y, Gou M, Yi T, Yang L, Liu L, Lin X, Su D, Wei Y, Zhao X.

Int J Med Sci. 2015 May 8;12(5):397-406. doi: 10.7150/ijms.10929. eCollection 2015.

5.

Efficient inhibition of an intraperitoneal xenograft model of human ovarian cancer by HSulf-1 gene delivered by biodegradable cationic heparin-polyethyleneimine nanogels.

Liu P, Gou M, Yi T, Xie C, Qi X, Zhou S, Deng H, Wei Y, Zhao X.

Oncol Rep. 2012 Feb;27(2):363-70. doi: 10.3892/or.2011.1550. Epub 2011 Nov 11.

PMID:
22086394
6.

Efficient inhibition of ovarian cancer by short hairpin RNA targeting claudin-3.

Sun C, Yi T, Song X, Li S, Qi X, Chen X, Lin H, He X, Li Z, Wei Y, Zhao X.

Oncol Rep. 2011 Jul;26(1):193-200. doi: 10.3892/or.2011.1275. Epub 2011 Apr 20.

PMID:
21519794
7.

Efficient inhibition of ovarian cancer by truncation mutant of FILIP1L gene delivered by novel biodegradable cationic heparin-polyethyleneimine nanogels.

Xie C, Gou ML, Yi T, Deng H, Li ZY, Liu P, Qi XR, He X, Wei Y, Zhao X.

Hum Gene Ther. 2011 Nov;22(11):1413-22. doi: 10.1089/hum.2011.047. Epub 2011 Jun 8.

PMID:
21513424
8.

Adenoviral vectors modified by heparin-polyethyleneimine nanogels enhance targeting to the lung and show therapeutic potential for pulmonary metastasis in vivo.

Wei W, Mu Y, Li X, Gou M, Zhang H, Luo S, Men K, Mao Y, Qian Z, Yang L.

J Biomed Nanotechnol. 2011 Dec;7(6):768-75.

PMID:
22416575
9.

Enhanced antitumor effect of biodegradable cationic heparin-polyethyleneimine nanogels delivering FILIP1LΔC103 gene combined with low-dose cisplatin on ovarian cancer.

Xie C, Gou M, Yi T, Qi X, Liu P, Wei Y, Zhao X.

Oncotarget. 2017 Jul 22;8(44):76432-76442. doi: 10.18632/oncotarget.19464. eCollection 2017 Sep 29.

10.

Efficient inhibition of lung cancer in murine model by plasmid-encoding VEGF short hairpin RNA in combination with low-dose DDP.

Ma YP, Yang Y, Zhang S, Chen X, Zhang N, Wang W, Cao ZX, Jiang Y, Zhao X, Wei YQ, Deng HX.

J Exp Clin Cancer Res. 2010 May 25;29:56. doi: 10.1186/1756-9966-29-56.

11.

Folate-linked lipoplexes for short hairpin RNA targeting claudin-3 delivery in ovarian cancer xenografts.

He ZY, Wei XW, Luo M, Luo ST, Yang Y, Yu YY, Chen Y, Ma CC, Liang X, Guo FC, Ye TH, Shi HS, Shen GB, Wang W, Gong FM, He G, Yang L, Zhao X, Song XR, Wei YQ.

J Control Release. 2013 Dec 28;172(3):679-89. doi: 10.1016/j.jconrel.2013.10.015. Epub 2013 Oct 18.

PMID:
24144916
12.

Gene therapy for C-26 colon cancer using heparin-polyethyleneimine nanoparticle-mediated survivin T34A.

Zhang L, Gao X, Men K, Wang B, Zhang S, Qiu J, Huang M, Gou M, Huang N, Qian Z, Zhao X, Wei Y.

Int J Nanomedicine. 2011;6:2419-27. doi: 10.2147/IJN.S23582. Epub 2011 Oct 19.

13.

Antitumoral efficacy by systemic delivery of heparin conjugated polyethylenimine-plasmid interleukin-15 complexes in murine models of lung metastasis.

Zhou X, Li X, Gou M, Qiu J, Li J, Yu C, Zhang Y, Zhang N, Teng X, Chen Z, Luo C, Wang Z, Liu X, Shen G, Yang L, Qian Z, Wei Y, Li J.

Cancer Sci. 2011 Jul;102(7):1403-9. doi: 10.1111/j.1349-7006.2011.01956.x. Epub 2011 May 12.

14.

Enhancement of cisplatin sensitivity in lung cancer xenografts by liposome-mediated delivery of the plasmid expressing small hairpin RNA targeting Survivin.

Tian H, Liu S, Zhang J, Zhang S, Cheng L, Li C, Zhang X, Dail L, Fan P, Dai L, Yan N, Wang R, Wei Y, Deng H.

J Biomed Nanotechnol. 2012 Aug;8(4):633-41.

PMID:
22852473
15.

Synergistic antitumor effect of AAV-mediated TRAIL expression combined with cisplatin on head and neck squamous cell carcinoma.

Jiang M, Liu Z, Xiang Y, Ma H, Liu S, Liu Y, Zheng D.

BMC Cancer. 2011 Feb 3;11:54. doi: 10.1186/1471-2407-11-54.

16.

[Effect and mechanism of gene therapy of lentivirus mediated RhoA shRNA on ovarian cancer xenograft in vivo].

Jiang WY, Kang JL, Wang XX, Yang WJ, Nie ML, Zhou C.

Zhonghua Fu Chan Ke Za Zhi. 2013 Oct;48(10):778-83. Chinese.

PMID:
24406137
17.

Enhancement of therapeutic effectiveness by combining liposomal honokiol with cisplatin in ovarian carcinoma.

Liu Y, Chen L, He X, Fan L, Yang G, Chen X, Lin X, DU L, Li Z, Ye H, Mao Y, Zhao X, Wei Y.

Int J Gynecol Cancer. 2008 Jul-Aug;18(4):652-9. Epub 2007 Sep 24.

PMID:
17892458
18.

Cationic liposome-mediated nitric oxide synthase gene therapy enhances the antitumor effects of cisplatin in lung cancer.

Ye S, Yang W, Wang Y, Ou W, Ma Q, Yu C, Ren J, Zhong G, Shi H, Yuan Z, Su X, Zhu W.

Int J Mol Med. 2013 Jan;31(1):33-42. doi: 10.3892/ijmm.2012.1171. Epub 2012 Nov 1.

PMID:
23128378
19.

Claudin-3 and claudin-4 regulate sensitivity to cisplatin by controlling expression of the copper and cisplatin influx transporter CTR1.

Shang X, Lin X, Manorek G, Howell SB.

Mol Pharmacol. 2013 Jan;83(1):85-94. doi: 10.1124/mol.112.079798. Epub 2012 Oct 10.

20.

Efficient inhibition of ovarian cancer by degradable nanoparticle-delivered survivin T34A gene.

Luo L, Du T, Zhang J, Zhao W, Cheng H, Yang Y, Wu Y, Wang C, Men K, Gou M.

Int J Nanomedicine. 2016 Feb 2;11:501-12. doi: 10.2147/IJN.S93496. eCollection 2016.

Supplemental Content

Support Center